Central and Peripheral 24h BP and the Association to Autonomic Neuropathy and Diabetic Nephropathy in Type 1 Diabetic Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 1 Diabetes
- Sponsor
- Steno Diabetes Center Copenhagen
- Enrollment
- 650
- Locations
- 1
- Primary Endpoint
- Ambulatory blood pressure (AMBP)
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The aim of the study is to evaluate the prevalence of abnormal nocturnal blood pressure (BP) in patients with type 1 diabetes. The investigators wish to gain knowledge on the relation between central and peripheral 24 hour BP and a possible association to late complications in diabetes.
Investigators
Peter Rossing
Senior Physician, DMSc
Steno Diabetes Center Copenhagen
Eligibility Criteria
Inclusion Criteria
- •Type 1 diabetes
- •more than 18 years of age
Exclusion Criteria
- •End Stage Renal Disease (ESRD)
- •other kidney disease than diabetic nephropathy
Outcomes
Primary Outcomes
Ambulatory blood pressure (AMBP)
Time Frame: 2 years
The participants are seen once (cross-sectional) and we measure AMBP in order for us to investigate any association between AMBP and other parameters such as age, duration of diabetes, albuminuria status and other diabetic complications.
Secondary Outcomes
- Diabetic late complications(2 years)